Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: Results from the clinical trials network

Substance Use and Misuse

Volumn 46, Issue 14, 2011, Pages 1716-1725

  Pilowsky, Daniel J ^a   Wu, Li Tzy ^b   Burchett, Bruce ^b   Blazer, Dan G ^b   Ling, Walter ^c  

^a Howard Hughes Medical Institute   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamines; Cocaine; Depression; Heroin; High risk behaviors; HIV; Injection drug use; Opiates; Substance abuse; Substance dependence

Indexed keywords

ADDICTION; ADOLESCENT; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG ABUSE; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; OPIATE ADDICTION; PSYCHOLOGICAL ASPECT; SEXUAL BEHAVIOR;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; BEHAVIOR, ADDICTIVE; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; RISK-TAKING; SEXUAL BEHAVIOR;

EID: 80055095834     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.611960     Document Type: Article

References (47)

1. Arria, A. M., Fuller, C., Strathdee, S. A., Latkin, C., & Vlahov, D. (2002). Drug dependence among young recently initiated injection drug users. Journal of Drug Issues, 32(4), 1089-1102.
2. Balon, R. (2006). Review of depression. Treatment strategies and management. Annals of Clinical Psychiatry, 18(4), 277-278.
3. Brewer, T. H., Zhao, W., Metsch, L. R., Coltes, A., & Zenilman, J. (2007). High-risk behaviors in women who use crack: Knowledge of HIV serostatus and risk behavior. Annals of Epidemiology, 17(7), 533-539.
4. Brown, L. K., Tolou-Shams, M., Lescano, C., Houck, C., Zeidman, J., Pugatch,D., et al. (2006). Depressive symptoms as a predictor of sexual risk among African American adolescents and young adults. Journal of Adolescent Health, 39(3), 444.e441-e448.
5. Centers for Disease & Prevention. 2006). Methamphetamine use and HIV risk behaviors among heterosexual men-Preliminary results from five northern California counties, December 2001- November 2003. MMWR - Morbidity & Mortality Weekly Report 55 10 273-277.
6. Chen, V. C.-H., Lin, T.-Y., Lee, C. T.-C., Lai, T.-J., Chen, H., Ferri, C. P., et al. (2010). Suicide attempts prior to starting methadone maintenance treatment in Taiwan. Drug & Alcohol Dependence, 109(1-3), 139-143.
7. Cohen, P., & Cohen, J. (1984). The clinician's illusion. Archives of General Psychiatry, 41(12), 1178-1182.
8. Crepaz, N., & Marks, G. (2001). Are negative affective states associated with HIV sexual risk behaviorŝ A meta-analytic review. Health Psychology, 20(4), 291-299.
9. Darke, S., Hall, W., Heather, N., Ward, J., & Wodak, A. (1991). The reliability and validity of a scale tomeasure HIV risk-taking behaviour among intravenous drug users. AIDS, 5(2), 181-185.
10. Des Jarlais, D. C., Braine, N., Yi, H., & Turner, C. (2007). Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs. AIDS Education & Prevention, 19(2), 111-123.
11. Fuller, C. M., Vlahov, D., Ompad, D. C., Shah, N., Arria, A., & Strathdee, S. A. (2002). High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case-control study. Drug and Alcohol Dependence, 66(2), 189-198.
12. Hasin,D. S., Stinson, F. S.,Ogburn, EßGrant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830-842.
13. Kalichman, S. C., & Weinhardt, L. (2001). Negative affect and sexual risk behavior: Comment on Crepaz and Marks (2001). Health Psychology, 20(4), 300-301.
14. Kang, S. Y., & De Leon, G. (1993). Correlates of drug injection behaviors among methadone outpatients. American Journal of Drug & Alcohol Abuse, 19(1), 107-118.
15. Kennedy, N. (2005). Review of treating depression effectively. Psychological Medicine: A Journal of Research in Psychiatry and the Allied Sciences, 35(4), 596-597.
16. Khan,M. R., Kaufman, J. S., Pence, B.W., Gaynes, B. N., Adimora, A. A.,Weir, S. S., et al. (2009). Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. Archives of Pediatrics & Adolescent Medicine, 163(7), 644-652.
17. Koblin, B. A., Murrill, C., Camacho, M., Xu, G., Liu, K.-L., Raj- Singh, S., et al. (2007). Amphetamine use and sexual risk among men who have sex with men: Results from the National HIV Behavioral Surveillance study-New York City. Substance Use & Misuse, 42(10), 1613-1628.
18. Kosunen, E., Kaltiala-Heino, R., Rimpel̈a, M., & Laippala, P. (2003). Risk-taking sexual behaviour and self-reported depression in middle adolescence-a school-based survey. Child: Care, Health & Development, 29(5), 337-344.
19. Latkin, C. A., & Mandell, W. (1993). Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sample. International Journal of the Addictions, 28(14), 1601-1612.
20. Lehrer, J. A., Shrier, L. A., Gortmaker, S., & Buka, S. (2006). Depressive symptoms as a longitudinal predictor of sexual risk behaviors among US middle and high school students. Pediatrics, 118(1), 189-200.
21. Ling, W., Amass, L., Shoptaw, S., Annon, J. J., Hillhouse, M., Babcock, D., et al. (2005). A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction, 100(8), 1090-1100.
22. Maddux, J. F., Desmond, D. P.,&Costello, R. (1987). Depression in opioid users varies with substance use status. American Journal of Drug & Alcohol Abuse, 13(4), 375-385.
23. Mandell, W., Kim, J., Latkin, C., & Suh, T. (1999). Depressive symptoms, drug network, and their synergistic effect on needlesharing behavior among street injection drug users. American Journal of Drug & Alcohol Abuse, 25(1), 117-127.
24. McGahan, P. L., Parante, R., & McLellan, A. T. (1982). Composite scores from the addiction severity index. Washington, DC: National Institute on Drug Abuse Project DA02554 and the Veterans Administration.
25. McHorney, C. A., Ware, J. E., Jr., Lu, J. F., & Sherbourne, C. D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32(1), 40-66.
26. McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247-263.
27. McLellan, A. T., Luborsky, L., Cacciola, J., Griffith, J., Evans, F., Barr, H. L., et al. (1985). New data from the Addiction Severity Index. Reliability and validity in three centers. Journal of Nervous & Mental Disease, 173(7), 412-423.
28. Neaigus, A., Miller, M., Friedman, S. R., & Des Jarlais, D. C. (2001). Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. Journal of Infectious Diseases, 184(3), 359-363.
29. Newville, H., & Haller, D. L. (2010). Psychopathology and transmission risk behaviors in patients with HIV/AIDS. AIDS Care, 22(10), 1259-1268.
30. Page, J. B., Shapshak, P., Duran, E. M., Even, G., Moleon- Borodowski, I., & Llanusa-Cestero, R. (2006). Detection of HIV-1 in injection paraphernalia: Risk in an era of heightened awareness. AIDS Patient Care STDS, 20(8), 576-585.
31. Perdue, T., Hagan, H., Thiede, H., & Valleroy, L. (2003). Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Education and Prevention, 15(1), 81-92.
32. Petry, N. M. (2001). Reliability of drug users' self-reported HIV risk behaviors using a brief, 11-item scale. Substance Use & Misuse, 36(12), 1731-1747.
33. Pilowsky,D. J.,Keyes, K. M.,&Hasin,D. S. (2009).Adverse childhood events and lifetime alcohol dependence. American Journal of Public Health, 99(2), 258-263.
34. Plotzker, R. E., Metzger, D. S., & Holmes, W. C. (2007). Childhood sexual and physical abuse histories, PTSD, depression, and HIV risk outcomes in women injection drug users: A potential mediating pathway. American Journal on Addictions, 16(6), 431-438.
35. Romach,M. K., Sproule, B. A., Sellers, E.M., Somer, G., & Busto, U. E. (1999). Long-term codeine use is associated with depressive symptoms. Journal of Clinical Psychopharmacology, 19(4), 373-376.
36. Rubin, A. G., Gold, M. A., & Primack, B. A. (2009). Associations between depressive symptoms and sexual risk behavior in a diverse sample of female adolescents. Journal of Pediatric & Adolescent Gynecology, 22(5), 306-312.
37. Sherman, S. G., Fuller, C. M., Shah, N., Ompad, D. V., Vlahov, D., & Strathdee, S. A. (2005). Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: The need for early intervention. Journal of Psychoactive Drugs, 37(4), 437-443.
38. Shrier, L. A., Harris, S. K., Sternberg, M., & Beardslee, W. R. (2001). Associations of depression, self-esteem, and substance use with sexual risk among adolescents. Preventive Medicine, 33(3), 179-189.
39. Stein, M. D., Solomon, D. A., Herman, D. S., Anderson, B. J., & Miller, I. (2003). Depression severity and drug injection HIV risk behaviors. American Journal of Psychiatry, 160(9), 1659-1662.
40. Strain, E. C. (2002). Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clinical Journal of Pain, 18(4 Suppl.), S14-S27.
41. Strathdee, S. A., Patrick, D. M., Archibald, C. P., Ofner, M., Cornelisse, P. G., Rekart, M., et al. (1997). Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction, 92(10), 1339-1347.
42. Strathdee, S. A., & Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80(4 Suppl. 3), iii7-iii14.
43. Substance and Mental Health Services Administration. (2004). The DASIS Report: Primary Metamphetamine/Amphetamine Treatment Admissions, 1992-2002. Rockville, MD: Office of Applied Studies, Substance and Mental Health Services Administration.
44. Tai, B., Sparenborg, S., Liu, D., & Straus, M. (2011). The National Drug Abuse Treatment Clinical Trials Network: Forging a partnership between research knowledge and community practice. Substance Abuse and Rehabilitation, 2, 21-28.
45. Teesson, M., Havard, A., Fairbairn, S., Ross, J., Lynskey, M., & Darke, S. (2005). Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence, correlates and treatment seeking. Drug & Alcohol Dependence, 78(3), 309-315.
46. Testa, C. R., & Steinberg, L. (2010). Depressive symptoms and health-related risk-taking in adolescence. Suicide & Life- Threatening Behavior, 40(3), 298-305.
47. Williams, C. T., & Latkin, C. A. (2005). The role of depressive symptoms in predicting sex with multiple and high-risk partners. Journal of Acquired Immune Deficiency Syndromes, 38(1), 69-73.